TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive Special Report on Cancer Centers: Three cancer centers win $9 million core grants, 11 of 13 competitors cut due to NCI budget shortfall. January 16, 2004